BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28094120)

  • 1. Omalizumab-associated eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Nazir S; Tachamo N; Fareedy SB; Khan MS; Lohani S
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):372-374.e1. PubMed ID: 28094120
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of eosinophilic granulomatosis with poliangiitis (Churg-Strauss syndrome) and brain tumor in a patient after more than 7 years of omalizumab use: A case report.
    Borekci S; Aydin O; Hatemi G; Gemicioglu B
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):134-7. PubMed ID: 25816417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of omalizumab-associated eosinophilic granulomatosis with polyangiitis.
    Yamaki Y; Hayashi D; Honda K; Imai H; Takada H
    Pediatr Int; 2021 Sep; 63(9):1119-1121. PubMed ID: 34170601
    [No Abstract]   [Full Text] [Related]  

  • 4. Churg-Strauss syndrome associated with omalizumab.
    Puéchal X; Rivereau P; Vinchon F
    Eur J Intern Med; 2008 Jul; 19(5):364-6. PubMed ID: 18549941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Churg-Strauss syndrome under omalizumab treatment: a rare visceral manifestation].
    Szwarc D; Veillon F; Moser T; Averous G; De Blay F; Riehm S
    J Radiol; 2009 Nov; 90(11 Pt 1):1737-9. PubMed ID: 19953062
    [No Abstract]   [Full Text] [Related]  

  • 6. Churg-Strauss syndrome in a patient treated with omalizumab.
    Cisneros C; Segrelles G; Herráez L; Gonzalez A; Girón R
    J Investig Allergol Clin Immunol; 2013; 23(7):515-6. PubMed ID: 24654320
    [No Abstract]   [Full Text] [Related]  

  • 7. Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
    Carson LN; Pradhan A; Subramanian D
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34326107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis?
    Latorre M; Baldini C; Seccia V; Notarstefano C; Della Rossa A; Tani C; Talarico R; Mosca M; Paggiaro PL
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S91-2. PubMed ID: 23075542
    [No Abstract]   [Full Text] [Related]  

  • 9. Churg-strauss syndrome in patients treated with omalizumab.
    Wechsler ME; Wong DA; Miller MK; Lawrence-Miyasaki L
    Chest; 2009 Aug; 136(2):507-518. PubMed ID: 19411292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Churg-Strauss syndrome associated with montelukast therapy.
    Kaliterna DM; Perković D; Radić M
    J Asthma; 2009 Aug; 46(6):604-5. PubMed ID: 19657903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omalizumab administration in Churg-Strauss syndrome.
    Giavina-Bianchi P; Kalil J
    Eur J Intern Med; 2009 Oct; 20(6):e139. PubMed ID: 19782907
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients.
    Jachiet M; Samson M; Cottin V; Kahn JE; Le Guenno G; Bonniaud P; Devilliers H; Bouillet L; Gondouin A; Makhlouf F; Meaux-Ruault N; Gil H; Bienvenu B; Coste A; Groh M; Giraud V; Dominique S; Godeau B; Puéchal X; Khouatra C; Ruivard M; Le Jeunne C; Mouthon L; Guillevin L; Terrier B;
    Arthritis Rheumatol; 2016 Sep; 68(9):2274-82. PubMed ID: 26946346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab for asthma.
    Winchester DE; Jacob A; Murphy T
    N Engl J Med; 2006 Sep; 355(12):1281-2. PubMed ID: 16990394
    [No Abstract]   [Full Text] [Related]  

  • 14. Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?
    Cazzola M; Mura M; Segreti A; Mattei MA; Rogliani P
    Allergy; 2009 Sep; 64(9):1389-90. PubMed ID: 19392997
    [No Abstract]   [Full Text] [Related]  

  • 15. Omalizumab treatment associated with Churg-Strauss vasculitis.
    Bargagli E; Rottoli P
    Int Arch Allergy Immunol; 2008; 145(3):268. PubMed ID: 17921677
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukotriene antagonists and Churg-Strauss syndrome: the smoking gun.
    Stirling RG; Chung KF
    Thorax; 1999 Oct; 54(10):865-6. PubMed ID: 10491447
    [No Abstract]   [Full Text] [Related]  

  • 17. The Role of Omalizumab in Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Comment on the Article by Jachiet et al.
    Detoraki A; Varricchi G; Genovese A; Marone G; Spadaro G
    Arthritis Rheumatol; 2017 Apr; 69(4):868-870. PubMed ID: 27992689
    [No Abstract]   [Full Text] [Related]  

  • 18. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment.
    Green RL; Vayonis AG
    Lancet; 1999 Feb; 353(9154):725-6. PubMed ID: 10073523
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment.
    Ruppert AM; Averous G; Stanciu D; Deroide N; Riehm S; Poindron V; Pauli G; Debry C; de Blay F
    J Allergy Clin Immunol; 2008 Jan; 121(1):253-4. PubMed ID: 18206510
    [No Abstract]   [Full Text] [Related]  

  • 20. Omalizumab in eosinophilic granulomatosis with polyangiitis: friend or foe? A systematic literature review.
    Basta F; Mazzuca C; Nucera E; Schiavino D; Afeltra A; Antonelli Incalzi R
    Clin Exp Rheumatol; 2020; 38 Suppl 124(2):214-220. PubMed ID: 32083537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.